(Q45844527)

16 December 2017

title

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma (English)

1 reference

16 December 2017

0 references

0 references

1 reference

1 reference

1 reference

8

M Houghton

1 reference

16 December 2017

author name string

M Colombo

1

1 reference

16 December 2017

G Kuo

2

1 reference

16 December 2017

Q L Choo

3

1 reference

16 December 2017

M F Donato

4

1 reference

16 December 2017

E Del Ninno

5

1 reference

16 December 2017

M A Tommasini

6

1 reference

16 December 2017

N Dioguardi

7

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

16 December 2017

published in

The Lancet

1 reference

16 December 2017

volume

2

1 reference

16 December 2017

issue

8670

1 reference

16 December 2017

page(s)

1006-1008

1 reference

16 December 2017

NIH conference. Hepatocellular carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

7 January 2021

Relationship between hepatocellular carcinoma and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

7 January 2021

Cirrhosis and the aetiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

7 January 2021

Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

7 January 2021

Risk factors for hepatocellular carcinoma in Northern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

7 January 2021

Hepatitis C virus antibodies among risk groups in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

7 January 2021

A multicenter, prospective study of posttransfusion hepatitis in Milan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

7 January 2021

Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

7 January 2021

Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

7 January 2021

Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991016-7

1 reference

7 January 2021

10.1016/S0140-6736(89)91016-7

Identifiers

DOI

1 reference

16 December 2017

PubMed ID

2572740

1 reference

16 December 2017